U.S. Supreme Court backs quicker approval of drug copies
Allen Cone United Press International WASHINGTON, D.C. (UPI) -- The U.S. Supreme Court unanimously ruled Monday that biotech drug copies -- called biosimilars -- can become available to consumers quicker. Writing for the court, Associate Justice Clarence Thomas said that the decision was not based on policy arguments, but rather, the "plain language" of the biosimilar statue itself. The nine justices overturned a lower court's decision that had prevented Swiss pharmaceutical company Novartis AG from selling its injectable version of […]
